Digestive System Disease Clinical Trials

7 recruiting

Digestive System Disease Trials at a Glance

14 actively recruiting trials for digestive system disease are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Houston, London, and Barcelona. Lead sponsors running digestive system disease studies include Centre Paul Strauss, EP Plus Group Sdn Bhd, and Boston Children's Hospital.

Browse digestive system disease trials by phase

Treatments under study

About Digestive System Disease Clinical Trials

Looking for clinical trials for Digestive System Disease? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Digestive System Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Digestive System Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 3

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled156 locationsNCT07222800
Recruiting
Not Applicable

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

Postoperative ComplicationsAnastomotic LeaksAnastomotic Complication+8 more
Medtronic - MITG137 enrolled8 locationsNCT07351071
Recruiting
Not Applicable

Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

NeoplasmsDigestive System Disease
Centre Paul Strauss144 enrolled1 locationNCT05066139
Recruiting
Phase 1

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

Metastatic CancerGastrointestinal NeoplasmsGastrointestinal Diseases+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC278 enrolled30 locationsNCT05489237
Recruiting
Not Applicable

Immune Responses to Gluten

Celiac DiseaseCeliac Disease in ChildrenIntestinal Disease+4 more
Boston Children's Hospital400 enrolled2 locationsNCT05209568
Recruiting

Early Diagnosis of Upper Digestive Tract Disease

Squamous Cell CarcinomaDigestive System DiseaseDiagnose Disease+1 more
Imperial College London180 enrolled1 locationNCT04475952
Recruiting
Phase 4

Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

Pathologic ProcessesIntestinal DiseaseGastrointestinal Diseases+5 more
EP Plus Group Sdn Bhd60 enrolled1 locationNCT06271538
Recruiting
Not Applicable

Intestinal Organoids

Crohn DiseaseDigestive System DiseasesInflammatory Bowel Disease, Ulcerative Colitis Type
Rennes University Hospital90 enrolled1 locationNCT05294107
Recruiting
Not Applicable

Impact Assessment of Abdominal Massage on Feeding Tolerance of Preterms

Digestive System DiseasePreterm Birth Complication
University Hospital, Clermont-Ferrand120 enrolled1 locationNCT06351202
Recruiting

OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.

NeoplasmsNeoplasms by SitePancreatic Neoplasm+5 more
OncoSil Medical Limited500 enrolled9 locationsNCT04493632
Recruiting
Not Applicable

Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.

Head and Neck NeoplasmsEsophageal NeoplasmsNeoplasms+6 more
Taipei Veterans General Hospital, Taiwan20 enrolled1 locationNCT06365866
Recruiting
Phase 2

XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma

Gastric CancerGastroesophageal-junction CancerCarcinoma+4 more
The First Affiliated Hospital with Nanjing Medical University80 enrolled1 locationNCT05494060
Recruiting

Spanish Series of Patients Treated With the Radionuclide Lutetium177

Stomach NeoplasmsNeuroendocrine TumorsNeoplasms+15 more
Sociedad Española de Medicina Nuclear e Imagen Molecular5,000 enrolled20 locationsNCT04949282
Recruiting
Phase 2

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsNeoplasms by Site+8 more
Jiangxi Provincial Cancer Hospital30 enrolled1 locationNCT05252078